Eugene Shenderov, MD, PhD

Professional Titles

Co-Director, Prostate Cancer Multidisciplinary Clinic

Primary Academic Title

Associate Professor of Oncology

LinkedIn

https://www.linkedin.com/in/eugene-shenderov-m-d-d-phil-facp-46384a7b/

Find a Clinical Trial

Research Interests

Cancer Biomarkers, Cancer Immunotherapy, Prostate Cancer, Targeted Cancer Therapies

Lab Website

Eugene Shenderov Laboratory

• The Shenderov Lab focuses on the elucidation of the mechanisms of immune response and resistance to immunotherapy in Prostate Cancer. This has led to clinical and basic research investigating the presumptive checkpoint inhibitor B7-H3. In pursuit of understanding biomarkers or resistance and response, and regulatory molecules of immune response, we utilize artificial intelligence, immunogenomics, and spatial proteomics and transcriptomics in the laboratory and at the bedside using clinical trial correlative samples.

Google Scholar - Publications

https://scholar.google.com/citations?user=YarQeqEAAAAJ&hl=en

PubMed - Publications

https://pubmed.ncbi.nlm.nih.gov/?term=eugene+shenderov&sort=pubdate&size=200

Honors

• Annual Robert & Susan Hollander Foundation Prostate Cancer Research Awardee, 2023
• ASCO Advocacy Senator's Club Champion, 2022
• Fellow of the American College of Physicians (FACP), American College of Physicians, 2021
• ASCO Young Investigator Award, American Society of Clinical Oncology, 2019
• PCF Young Investigator Award, Prostate Cancer Foundation (PCF), 2019
• 125 Johns Hopkins Heroes Award, Johns Hopkins, 2018
• DoD Prostate Cancer Physician Research Award, Department of Defense, 2018
• Johns Hopkins Physician Scientist Training Program Scholar, Johns Hopkins, 2017
• Alpha Omega Alpha, AOA, 2015
• National Institutes of Health-Oxford Biomedical Research Scholarship, NIH/Oxford University, 2005